MiRNA-155 increased expression also re-sensitized drug-resistant MM cells to BTZ, causing cell death via targeting tumor necrosis factor-α-induced protein 8 (TNFAIP8), a negative controller of programmed cell death. Here, TNFAIP8 is linked to Miyoshi myopathy.